Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and environmental walking effects on attention in children with ADHD
ACTRN12616000125426Phase 2Completed
- Sponsor
- University of Copenhagen
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (4 arms), sponsored by University of Copenhagen. Primary endpoint: Executive attention score. Started Feb 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ACTRN12616000125426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000125426.